Phase 3Completed
Effect of Empagliflozin on Macrovascular and Microvascular Circulation and on Endothelium Function
Randomized, Double-blind, Placebo Controlled, Crossover Clinical Study to Analyse the Effect of Empagliflozin on Macrovascular and Microvascular Circulation and on Endothelium Function
- Sponsor
- University of Erlangen-Nürnberg Medical School (Academic or other)
- Enrolment
- 74 enrolled
- Conditions
- Diabetes Mellitus Type 2
- Interventions
- Empagliflozin; Placebo
- Ages
- adults, older adults
- Registry
- NCT02471963
From the registry
Empagliflozin may lead to improved vascular and endothelial function in the macro- (pulse wave reflection) and microcirculation (retinal circulation) and improve cardiovascular risk factors, imparticular by effectively controlling hyperglycemia, arterial hypertension and obesity.
Primary outcomes
- Effect of empagliflozin after 6 weeks of treatment on macrocirculation